Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-15-246836
Filing Date
2015-07-07
Accepted
2015-07-07 16:39:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d32237ds3.htm S-3 202059
2 EX-5.1 d32237dex51.htm EX-5.1 6240
3 EX-23.1 d32237dex231.htm EX-23.1 2462
4 GRAPHIC g322371new.jpg GRAPHIC 5638
5 GRAPHIC g32237new.jpg GRAPHIC 6169
  Complete submission text file 0001193125-15-246836.txt   228492
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-205533 | Film No.: 15976926
SIC: 2835 In Vitro & In Vivo Diagnostic Substances